Sep 15, 2020
The Centers for Medicare & Medicaid Services proposes to fully phase in its new risk adjustment model for Medicare Advantage plans in calendar year 2022, as required by the 21st Century Cures Act, the agency announced yesterday.
Aug 4, 2020
The Centers for Medicare & Medicaid Services Aug. 4 released a proposed rule that would retroactively incorporate Medicare Advantage days into the Medicare fraction of a hospital’s disproportionate patient percentage for the Medicare Disproportionate Share Hospital program.
Jun 22, 2020
Beginning July 6, both traditional Medicare and Medicare Advantage plans will cover diagnostic COVID-19 laboratory tests for nursing home residents and patients through the remainder of the public health emergency, the Centers for Medicare & Medicaid Services announced Friday.
May 27, 2020
Over 1,750 Medicare Part D prescription drug plans and Medicare Advantage plans with prescription drug coverage have applied to offer lower insulin costs through the Part D Senior Savings Model for the 2021 plan year, the Centers for Medicare & Medicaid Services said.
May 27, 2020
The Centers for Medicare & Medicaid Services (CMS) May 22 released its final rule implementing policy changes for the Medicare Advantage (MA) and Part D plans contract year 2021.
Apr 8, 2020
The Centers for Medicare & Medicaid Services April 6 finalized updates and changes to its Medicare Advantage and Part D payment methodologies for calendar years 2021 and 2022.
Apr 6, 2020
The American Hospital Association appreciates the opportunity to comment on the Centers for Medicare & Medicaid Services’ proposed regulation regarding policy and technical changes to Medicare Advantage and Part D prescription drug program for Contract Years 2021 and 2022.
Mar 4, 2020
The Centers for Medicare & Medicaid Services should develop prior authorization measures for the Medicare Advantage Star Ratings Program to minimize care delays and protect patients from inappropriate care denials, AHA said in submitted comments.
Feb 14, 2020
If you continue building, will they still come? In a nutshell, that’s what some analysts wanted Humana Inc. President and CEO Bruce Broussard to answer on a recent earnings call regarding his company’s $600 million joint venture with private equity firm Welsh, Carson, Anderson…